CEO sold ~$91K of ADMA shares in the open market

Past results only. Not a forecast.

Record ID

0001140361-26-009899

Filed / recorded

Mar 18, 2026, 1:00 AM UTC

Added to OQRO

Oct 6, 2026, 9:54 PM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

ADMA BIOLOGICS, INC.

Issuer CIK

1368514

Ticker

ADMA

Reporting person

Adam S Grossman

Relationship

Director, Officer

Officer title

President and CEO

Security

Common Stock

Table

Non-derivative (Table I)

Transaction date

Mar 16, 2026

Transaction code

S

Shares / units

6,000

Price per share

$15.16

Acquired / disposed

Disposed (D)

Shares owned after

2,112,777

Ownership form

Direct

Amendment

No

1. Transaction was effected pursuant to a Rule 10b5-1 trading plan entered into between the Reporting Person and Fidelity Brokerage Services LLC on November 14, 2025.
2. The price reported in Column 4 is the price at which the shares were sold.
3. Includes, as of the transaction date, (i) 282,529 unvested RSUs granted on February 9, 2026, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (ii) 189,017 unvested RSUs out of 252,022 RSUs granted on February 19, 2025, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting;
4. (continued from footnote 2) (iii) 278,864 unvested RSUs out of 557,728 RSUs granted on February 26, 2024, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (iv) 143,424 unvested RSUs out of 573,695 RSUs granted on March 6, 2023 that will vest quarterly on each annual anniversary of the date of grant, over four years, subject to the Reporting Person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting;
5. (continued from footnote 3) and (v) 1,218,943 shares of common stock owned by the Reporting Person, which reflects prior purchases and the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes.